Membranes were washed three more times with TBS-T, and then the antibody-stained protein signal was amplified and visualized using SuperSignal (Thermo Fisher, 34577)
Semaglutide has more mature outcomes data on heart attack, stroke, and chronic kidney disease prevention
B.Garrido-MartnezM.et al (2019)
Eli Lilly published the results of its ATTAIN-1b trial for obesity in September 2025 7 , which compared orforglipron to placebo in more than 3,100 adults without diabetes, with a BMI of 30+ or 27-30 with an obesity-related complication including hypertension, dyslipidaemia, cardiovascular disease or obstructive sleep apnoea and a history of at least one patient-reported unsuccessful dietary effort to lose body weight, who have tried unsuccessfully to lose weight with diet alone
All participants were M0 at diagnosis with no metastatic disease
Dziaanie antyoksydacyjne i geroprotekcyjne (modele gryzoni) W modelach mysich i szczurzych (m.in